Brady W Dougan, a director at $HUMA, sold 1,100,000 shares of the company on 08-19-2025 for an estimated $1,792,999. We received data on the trade from a recent SEC filing. This was a sale of approximately 65.0% of their shares of this class of stock. Following this trade, they now own 591,685 shares of this class of $HUMA stock.
$HUMA Insider Trading Activity
$HUMA insiders have traded $HUMA stock on the open market 12 times in the past 6 months. Of those trades, 6 have been purchases and 6 have been sales.
Here’s a breakdown of recent trading of $HUMA stock by insiders over the last 6 months:
- BRADY W DOUGAN has made 0 purchases and 3 sales selling 2,241,045 shares for an estimated $3,733,191.
- LAURA E NIKLASON (President, CEO and Director) has made 0 purchases and 3 sales selling 2,241,045 shares for an estimated $3,733,191.
- KATHLEEN SEBELIUS purchased 50,000 shares for an estimated $66,000
- DALE A. SANDER (CFO and Chief Corp. Deve. Off.) purchased 20,000 shares for an estimated $30,600
- MICHAEL T. CONSTANTINO purchased 16,000 shares for an estimated $20,160
- SHAMIK J PARIKH (Chief Medical Officer) purchased 7,500 shares for an estimated $11,625
- WILLIAM JOHN SCHEESSELE (Chief Commercial Officer) purchased 6,493 shares for an estimated $9,999
- CHARLES BRUCE GREEN purchased 6,000 shares for an estimated $7,740
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$HUMA Hedge Fund Activity
We have seen 105 institutional investors add shares of $HUMA stock to their portfolio, and 88 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- HEIGHTS CAPITAL MANAGEMENT, INC removed 4,025,000 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $8,412,250
- RA CAPITAL MANAGEMENT, L.P. removed 3,312,356 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $6,922,824
- MARSHALL WACE, LLP added 2,590,394 shares (+5308.2%) to their portfolio in Q2 2025, for an estimated $5,413,923
- CITADEL ADVISORS LLC removed 2,287,143 shares (-78.5%) from their portfolio in Q2 2025, for an estimated $4,780,128
- TORONTO DOMINION BANK removed 2,131,390 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $4,454,605
- CENTERBOOK PARTNERS LP added 2,007,743 shares (+141.1%) to their portfolio in Q2 2025, for an estimated $4,196,182
- MONASHEE INVESTMENT MANAGEMENT LLC removed 2,000,000 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $4,179,999
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$HUMA Analyst Ratings
Wall Street analysts have issued reports on $HUMA in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- HC Wainwright & Co. issued a "Buy" rating on 08/12/2025
- D. Boral Capital issued a "Buy" rating on 08/11/2025
- Benchmark issued a "Buy" rating on 05/14/2025
To track analyst ratings and price targets for $HUMA, check out Quiver Quantitative's $HUMA forecast page.
$HUMA Price Targets
Multiple analysts have issued price targets for $HUMA recently. We have seen 5 analysts offer price targets for $HUMA in the last 6 months, with a median target of $14.0.
Here are some recent targets:
- Swayampakula Ramakanth from HC Wainwright & Co. set a target price of $3.0 on 08/12/2025
- Joshua Jennings from TD Cowen set a target price of $3.5 on 08/12/2025
- Jason Kolbert from D. Boral Capital set a target price of $25.0 on 08/11/2025
- Bruce Jackson from Benchmark set a target price of $14.0 on 05/14/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
